Menu

Deep Learning Allows for Cell Analysis Without Labeling

A new microscopy program requires no fluorescent markers to identify cell type, nuclei, and other characteristics.

Apr 12, 2018
Kerry Grens

This image shows the program “thinking,” as it considers what cellular structures to identify. IMAGE COURTESY OF DR. FINKBEINER, GLADSTONES INSTITUTES AND UCSFMicrographs of fluorescently labeled cells are undoubtedly beautiful, but they require invasive and sometimes disruptive or deadly protocols to get their glow. To avoid such perturbations, researchers have developed a computer program that can distinguish between cell types and identify subcellular structures, among other features—all without the fluorescent probes our human eyes rely on.

“This approach has the potential to revolutionize biomedical research,” Margaret Sutherland, program director at the National Institute of Neurological Disorders and Stroke, which partially funded the work, says in a statement.

The researchers, who published their work in Cell today (April 12), designed their a neural network, a program modeled after the brain, using an approach called deep learning, which uses data to recognize patterns, form rules, and apply those rules to new information. “We trained the neural network by showing it two sets of matching images of the same cells; one unlabeled and one with fluorescent labels,” coauthor Eric Christiansen, a software engineer at Google Accelerated Science, says a press release. “We repeated this process millions of times. Then, when we presented the network with an unlabeled image it had never seen, it could accurately predict where the fluorescent labels belong.”

With high-quality images, the program correctly identified nuclei within cells just about perfectly. It could also distinguish dead from living cells, spot neurons within groups of cells that included astrocytes and immature dividing cells, and even tell a dendrite from an axon.

“Techniques like this tend to have a democratizing effect,” opening up opportunities for smaller groups, Molly Maleckar, the director of mathematical modeling at the Allen Institute for Cell Science who was not involved in the study, tells Wired

The authors of the study say future work will look to optimize the network and boost its performance on certain tasks where it was less robust, such as picking out neuronal subtypes and finding axons in high-density cultures.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!